V. ,

I. T. Klip, J. Comin-colet, and A. A. Voors, Iron deficiency in chronic heart failure; an international pooled analysis, Am Heart J, vol.165, pp.575-82, 2013.

P. Ponikowski, A. A. Voors, and S. D. Anker, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.37, issue.27, pp.2129-2200, 2016.

U. Ramakrishanan, Prevalence of micronutrient malnutrition worldwide, Nutr Rev, vol.60, pp.46-52, 2002.

A. Cohen-solal, C. Leclercq, G. Deray, E. Lasocki, and J. J. Zambrowski, Iron deficiency: an emerging therapeutic target in heart failure, Heart, vol.100, pp.1414-1434, 2014.

J. J. Mcmurray, S. Adamopoulos, S. D. Anker, A. Auricchio, M. Bohm et al., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, Eur J Heart Fail, vol.14, pp.803-69, 2012.

, World Health Organization/United Nations University/UNICEF. Iron Deficiency Anaemia, Assessment, Prevention and Control: A Guide for Programme Managers, 2001.

P. Caddus, La carence martiale et son traitement, cahier de nutrition et de diététique, vol.4, pp.134-172, 2012.

G. R. Lee, J. Foerster, J. Lukens, and F. Paraskevas, Iron deficiency and iron-deficiency anemia Wintrobe's clinical hematology, pp.979-1010, 1998.

D. Schwartz, Méthodes statistiques à l'usage des médecins et biologistes. 4 ème édition. Paris: médecine sciences Flammarion

E. A. Jankowska, P. Rozentryt, and A. Witkowska, Iron deficiency: an ominous sign in patients with systolic chronic heart failure, Eur Heart J, vol.31, issue.15, pp.1872-80, 2010.

A. Cohen-solal and T. Damy, High prevalence of iron deficiency in patients with acute decompensated heart failure, Eur J Heart Fail, vol.16, pp.984-91, 2014.

D. O. Okonko, A. K. Mandal, and C. G. Missouris, Disordered iron homeostatis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival, J Am Coll Cardiol, vol.58, pp.1241-51, 2011.

G. Lewis, R. Malhtra, and F. Hernandez, Effect of Oral Iron Repletion on Exercise Capacity in Patients with Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial JAMA, vol.317, pp.1958-66, 2017.

S. D. Anker, C. Coletj, and G. Filippatos, Ferric carboxymaltose in patients with heart failure and iron deficiency, N Engl J Med, vol.361, pp.2426-2474, 2009.

J. E. Toblli, A. Lombrasa, and P. Duarte, Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart an renal insufficiency, J Am Coll Cardiol, vol.50, pp.1657-65, 2007.

P. Ponikowski, D. J. Van-veldhuisen, C. , and J. , Beneficial effects of long term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency, European Heart Journal, vol.36, pp.657-68, 2015.

D. J. Van-veldhuisen, P. Ponikowski, P. Van-der-meer, and M. Metra, Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT HF), Circulation, vol.136, issue.15, pp.1374-83, 2017.

T. Avni, L. Leibovici, and A. Gafter-gvili, Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis, Eur J Heart Fail, vol.14, pp.423-432, 2012.

M. Kapoor, M. D. Schleinitz, and A. Gemignani, Cardiovasc Hematol Disord Drug Targets, vol.13, pp.35-44, 2013.

J. M. Fernandez-real, A. Lopez-bermejo, and W. Ricart, Cross-talk between iron metabolism and diabetes, Diabetes, vol.51, issue.8, pp.2348-54, 2002.

J. M. Fernandez-real, D. Mcclain, and M. Manco, Mechanisms linking glucose homeostasis and iron metabolism toward the onset and progression of type 2 diabetes, Diabetes Care, vol.38, issue.11, pp.2169-76, 2015.

L. Rajagopal, S. Ganapathy, S. Arunachalam, V. Raja, and B. Ramraj, Does iron deficiency anaemia and its severity influence HbA1C level in non diabetics? An analysis of 150 cases, J Clin Diagn Res, vol.11, issue.2, pp.13-18, 2017.

O. Tarim, A. Kucukerdogan, U. Gunay, O. Eralp, and I. Ercan, Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus, Pediatr Int, vol.41, issue.4, pp.357-62, 1999.

E. Coban, M. Ozdogan, and A. Timuragaoglu, Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients, Acta Haematol, vol.112, issue.3, pp.126-134, 2004.

I. El-agouza, A. Shahla, A. Sirdah, and M. , The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis, Clin Lab Haematol, vol.24, issue.5, pp.285-294, 2002.

P. S. Hardikar, S. M. Joshi, D. S. Bhat, D. A. Raut, P. A. Katre et al., Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young Indians partly explained by hematological factors and iron deficiency anemia, Diabetes Care, vol.35, issue.4, pp.797-802, 2012.

J. I. Son, S. Y. Rhee, J. T. Woo, J. K. Hwang, S. O. Chin et al., Hemoglobin a1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects, Diabetes Metab J, vol.37, issue.5, pp.343-351, 2013.

B. Shanthi, C. Revathy, and A. Manjula-devi, Effect of iron deficiency on glycation of haemoglobin in nondiabetics, J Clin Diagn Res, vol.7, issue.1, pp.15-22, 2013.

R. D. Lopes, J. H. Alexander, and A. Sm, Apixaban for reduction in stroke and other thromboembolic events in AF (ARISTOTLE) trial: design and rationale, Am Heart J, vol.159, pp.331-340, 2010.

B. D. Westenbrink, M. D. Phd, M. Alings, M. D. Phd, C. B. Granger et al., Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial B, Am Heart J, vol.185, pp.140-149, 2017.

M. Keskin, D. Ural, S. Altay, O. Argan, E. B. Bo?rklu? et al., Iron deficiency and hematinic deficiencies in atrial fibrillation: A new insight into comorbidities, Turk Kardiyol Dern Ars, vol.46, pp.103-113, 2018.

R. Imai, T. Higuchi, M. Morimoto, R. Koyamada, and S. Okada, Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor, Intern Med, vol.57, pp.899-901, 2018.

Y. Lin, S. He, R. Feng, Z. Xu, W. Chen et al., Digoxin induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and druggene interaction network, Oncotarget, vol.22, issue.8, pp.57003-57014, 2017.